Search
FRAX716
go.drugbank.com/drugs/DB31795ExperimentalFRAX716 is a group I-specific p21-activated kinase (PAK) inhibitor which dramatically inhibits the phosphorylation of PAK and Mek1.[A274678]
Solabegron
go.drugbank.com/drugs/DB06190InvestigationalSolabegron (GW-427,353) is a selective β3 adrenoceptor agonist being developed for the treatment of overactive bladder and irritable bowel syndrome.
Ecopipam
go.drugbank.com/drugs/DB12273InvestigationalEcopipam has been used in trials studying the treatment of Tourette's Syndrome, Lesch-Nyhan Disease, Pathological Gambling, and Self-injurious Behavior.
S-3APG
go.drugbank.com/drugs/DB17419ExperimentalS-3APG (S-3-[3-amino-phthalimido]-glutarimide) is a derivative of thalidomide with dual activity against B-cell neoplasias.[A255168]
Iodocetylic acid I-123
go.drugbank.com/drugs/DB19593ExperimentalIodocetylic acid I-123 has a monoisotopic molecular weight of 378.14 Da.
Roxarsone
go.drugbank.com/drugs/DB11458ExperimentalVet approvedThe addition of this compound to poultry feed improves weight gain and feed efficiency as well as prevent the growth of coccidian parasites.
International brands: Ren-O-SalInhibitor of P38 Kinase
go.drugbank.com/drugs/DB01953ExperimentalInhibitor of P38 Kinase is a solid. This compound belongs to the indoles. These are compounds containing an indole moiety, which consists of a pyrrole ring fused to benzene to form 2,3-benzopyrrole.
Synonyms: Inhibitor of P38 KinaseVirginiamycin S1
go.drugbank.com/drugs/DB04805ExperimentalOne of the components of virginiamycin, a cyclic polypeptide antibiotic complex from streptomyces virginiae, s. Loidensis, s. Mitakaensis, s. Pristina-spiralis, s. Ostreogriseus, and others.
Gemogenovatucel-T
go.drugbank.com/drugs/DB17412InvestigationalFurin is a convertase involved in the activation of TGFβ-1 and TGFβ-2.[A255163] Gemogenovatucel-T is being investigated in the treatment of various cancers.
Pegsitacianine
go.drugbank.com/drugs/DB19098InvestigationalImaging Agent for the Detection of Cancer, in Patients With Unknown Primary Head and Neck Cancer (ILLUMINATE STUDY)). … Pegsitacianine is under investigation in clinical trial NCT05576974 (A Phase 2a, Single-dose, Open-label Study to Evaluate Diagnostic Performance and Safety of Pegsitacianine, an Intraoperative Fluorescence